MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

Authors:

Abstract
Adjuvant use improves the quality and quantity of the immune response to pandemic influenza vaccines.

This publication has 47 references indexed in Scilit: